[vc_row][vc_column][vc_column_text]
Op 25 juni 2021 vond het 2e symposium van de DTCG plaats.
09.15 – 9.30 Welcome Prof. dr. Thera P. Links, endocrinologist, University Medical Center Groningen
9.30 – 10.30 Session 1: New developments in thyroid cancer: part 1
9.30 Molecular stratification of benign and malignant Hurthle cell lesions
Prof. dr. Hans Morreau, pathologist, University Medical Center Leiden
9.45 Microcarcinoma and active surveillance
Dr. Tessa van Ginhoven, surgical oncologist, Erasmus Medical Center Rotterdam
10.00 Europe vs. US: hot topics
Prof. dr. Wim Oyen, nuclear medicine physician, Rijnstate Arnhem, Humanitas University Milan
10.15 Systematic approach of thyroid nodules by ultrasound
Drs. Habib Ahmad, radiologist, Erasmus Medical Center Rotterdam
10.30 – 11.00 Coffee and tea break
11.00 – 12.00 Session 2: The “other” thyroid cancers
11.00 Medullary Thyroid Cancer
Prof. dr. Schelto Kruijff, surgical oncologist, University Medical Center Groningen
Drs. Medard v.d. Broek, resident in endocrinology, University Medical Center Utrecht
11.20 Anaplastic Thyroid Cancer
Dr. Mischa de Ridder, radiation oncologist, University Medical Center Leiden
Drs. Pascal Jonker, surgical resident, University Medical Center Groningen
11.40 Pediatric Differentiated Thyroid Cancer
Dr. Hanneke van Santen, pediatric endocrinologist, Prinses Maxima Center Utrecht
Drs. Karin van der Tuin, resident in clinical genetics, University Medical Center Leiden
12.00 – 14.00 Lunch & poster pitches
Optional: poster pitches of national studies and new developments within the field of thyroid cancer
(viewing time 1 hour)
EfFECTS study
Lisanne Koster, University Medical Center Leiden and Nijmegen
COMBO study
Rosalie Koot, Radboud University Medical Center Nijmegen
Fertility after treatment for Differentiated Thyroid Carcinoma
Dr. Marloes Nies, University Medical Center Groningen
Long-term treatment effects after childhood Differentiated Thyroid Carcinoma
Bernadette Dekker/Antoinette Reichert, University Medical Center Groningen
The Genetic Background of Non-Medullary Thyroid Cancer in Pediatrics (GeNoThyPe)
Dr. Karin van der Tuin, University Medical Center Leiden
ERN EURACAN
Prof. dr. Alberto Pereira, endocrinologist, University Medical Center Leiden
HT vs. TTx with or without RAI in 1-4cm Papillary Thyroid Carcinoma
Pedro Rodriquez Schaap, Amsterdam University Medical Center
eNose
Prof. dr. Nicole Bouvy, Maastricht University Medical Center
National ATC consortium: shared forces
Dr. Mischa de Ridder, University Medical Center Leiden
“Patients’ and clinicians’ preferences for treatment of Graves’ disease: A discrete choice experiment”
Caroline van Kinschot, Erasmus Medical Center Rotterdam
14.00 – 15.00 Session 3: New developments in thyroid cancer: part 2
14.00 Systemic therapy: results and challenges
Prof. dr. Steven Waguespack, endocrinologist, MD Anderson Houston USA
14.30 The challenges of NIFTP and poorly differentiated tumors
Prof. dr. Kurt Schmidt, pathologist, Univerzitätsklinikum Essen
15.00 – 15.30 Coffee and tea break
15.30 – 16.30 Session 4: National MDO (multidisciplinary consultation)
Chair: Dr. Liesbeth Jansen, surgical oncologist, University Medical Center Groningen
Expert panel
Surgery: Dr. Anton Engelsman, Amsterdam University Medical Center
Endocrinology: Dr. Anouk van der Horst-Schrivers, Maastricht University Medical Center
Nuclear medicine: Dr. Marcel Janssen, Radboud University Medical Center
Pathology: Dr. Bettien van Hemel, University Medical Center Groningen
Medical Oncology: Dr. Jan Paul de Boer, Antonie van Leeuwenhoek Amsterdam
Radiation Oncology: Prof. dr. Hans Kaanders, Radboud University Medical Center Nijmegen
Radiology: Dr. Pim de Graaf, Amsterdam University Medical Center
16.30 Closing remarks
Prof. dr. Schelto Kruijff, surgical oncologist, University Medical Center Groningen
